Home/ Supplements/ Electrolytes/ Minerals Orange Raspberry Flavor

Minerals Orange Raspberry Flavor

product on market Liquid VitaMist Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

This product contains essential electrolytes including sodium, potassium, calcium, and magnesium chlorides. Strong evidence supports the role of these minerals in maintaining fluid balance and neuromuscular function. However, overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Minerals Orange Raspberry Flavor
Open Full PDF View on NIH DSLD →
Details

Label Data

0.47 mL
Serving Size
30
Servings
Mineral
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

1 mg (1% DV)
Market median: 4002.0mg (1 products) 21 studies (A:0, B:2)
1 mg (1% DV)
Market median: 99.0mg (52 products) 236 studies (A:4, B:113)
1 mg (1% DV)
Market median: 4002.0mg (1 products) 21 studies (A:0, B:2)
0.5 mg (1% DV)
Market median: 500.0mg (1 products) 316 studies (A:8, B:159)

Other Ingredients

Water, Purified Glycerin Xylitol Orange flavor Raspberry flavor Citric Acid Rebaudioside A Potassium Sorbate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Shake well before use. Spray directly into mouth and hold 5 seconds before swallowing. Take 1 serving (8 sprays) daily.

Warnings & Precautions

Caution: Keep out of reach of children.

Do not use if safety seal is damaged or missing. Consult your physician prior to use.

Formulation Notes

Contents made in USA Bottled and packaged in a cGMP facility

Powered by NDT Nebula Droplet Technology

Sugar free

Additional Information

Store in a cool, dry place.

Metadata

Product Details

UPC / SKU8 50023 24518 2
DSLD Entry Date2024-02-22
Product TypeMineral
FormLiquid
DSLD ID306847
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.